Antioxidant protection in a new animal model of cisplatin-induced ototoxicity

Hearing Research

Volumn 198, Issue 1-2, 2004, Pages 137-143

  Minami, Shujiro B ^a   Sha, Su Hua ^a   Schacht, Jochen ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Hearing loss; Reactive oxygen species; Salicylate

Indexed keywords

ANTIOXIDANT; CISPLATIN; SALICYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; COCHLEA; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HAIR CELL; HEARING LOSS; MORTALITY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; COCHLEA; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HAIR CELLS; HEARING LOSS, SENSORINEURAL; OXIDATIVE STRESS; RATS; RATS, INBRED F344; REACTIVE OXYGEN SPECIES; SODIUM SALICYLATE;

EID: 8844251566     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2004.07.016     Document Type: Article

References (38)

1. R. Arriagada, B. Bergman, A. Dunant, T. Le Chevalier, J.P. Pignon, and J. Vansteenkiste Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer New Engl. J. Med. 350 2004 351 360
2. J. Bernier, C. Domenge, M. Ozsahin, K. Matuszewska, J.L. Lefebvre, R.H. Greiner, J. Giralt, P. Maingon, F. Rolland, M. Bolla, F. Cognetti, J. Bourhis, A. Kirkpatrick, and M. van Glabbeke Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer New Engl. J. Med. 350 2004 1945 1952
3. G.J. Bosl, and RJ. Motzer Medical progress: testicular germ-cell cancer New Engl. J. Med. 337 1997 242 254
4. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. K.C. Campbell, L.P. Rybak, R.P. Meech, and L. Hughes D-methionine provides excellent protection from cisplatin ototoxicity in the rat Hear. Res. 102 1996 90 98
6. R.M. Cardinaal, J.C. de Groot, E.H. Huizing, J.E. Veldman, and G.F. Smoorenburg Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig Hear. Res. 144 2000 157 167
7. W.J. Clerici, K. Hensley, D.L. DiMartino, and D.A. Butterfield Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants Hear. Res. 98 1996 116 124
8. J.S. Cooper, T.F. Pajak, A.A. Forastiere, J. Jacobs, B.H. Campbell, S.B. Saxman, J.A. Kish, H.E. Kim, A.J. Cmelak, M. Rotman, M. Machtay, J.F. Ensley, K.S. Chao, C.J. Schultz, N. Lee, and K.K. Fu Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck New Engl. J. Med. 350 2004 1937 1944
9. T.L. Cornelison, and E. Reed Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin Gynecol. Oncol. 50 1993 147 158
10. T.C. Dinis, V.M. Maderia, and L.M. Almeida Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers Arch. Biochem. Biophys. 315 1994 161 169
11. M.J. Guitton, J. Caston, J. Ruel, R.M. Johnson, R. Pujol, and J.L. Puel Salicylate induces tinnitus through activation of cochlear NMDA receptors J. Neurosci. 23 2003 3944 3952
12. R.G. Hoop, C.J. Vecht, M.E. van der Burg, A. Elderson, W. Boogerd, J.J. Heimans, E.P. Vries, J.C. van Houwelingen, F.G. Jennekens, and W.H. Gispen Prevention of cisplatin neurotoxicity with an ACT(4-9) Hanalogue in patients with ovarian cancer New Engl. J. Med. 322 1990 89 94
13. T. Ishikawa, and F. Ali-Osman Glutathione-associated cis- diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance J. Biol. Chem. 268 1993 20116 20125
14. R.H. Julicher, L. Sterrenberg, G.R. Haenen, A. Bast, and J. Noordhoek Sex differences in the cellular defence system against free radicals from oxygen or drug metabolites in rat Arch. Toxicol. 56 1984 83 86
15. J.G. Kalkanis, C. Whitworth, and L.P. Rybak Vitamin E reduces cisplatin ototoxicity Laryngoscope 114 2004 538 542
16. T. Kamimura, C.A. Whitworth, and L.P. Rybak Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat Hear. Res. 131 1999 117 127
17. S.F. Klis, S.J. O'Leary, F.P. Hamers, J.C. De Groot, and G.F. Smoorenburg Reversible cisplatin ototoxicity in the albino guinea pig Neuroreport 28 2000 623 626
18. J. Lautermann, B. Song, J. McLaren, and J. Schacht Diet is a risk factor in cisplatin ototoxicity Hear. Res. 88 1995 47 53
19. G. Laurell, and U. Jungnelius High-dose cisplatin treatment: hearing loss and plasma concentrations Laryngoscope 100 1990 724 734
20. D.J. Leitao, and B.W. Blakley Quantification of sodium thiosulphate protection on cisplatin-induced toxicities J. Otolaryngol. 32 2003 146 150
21. G. Li, S.H. Sha, E. Zotova, J. Arezzo, T. Van de Water, and J. Schacht Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action Lab. Invest. 85 2002 585 596
22. M. Marty, P. Pouillart, S. Scholl, J.P. Droz, M. Azab, N. Brion, E. Pujade-Lauraine, B. Paule, D. Paes, and J. Bons Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis New Engl. J. Med. 322 1990 816 821
23. W.P. McGuire, W.J. Hoskins, M.F. Brady, P.R. Kucera, E.E. Partridge, K.Y. Look, D.L. Clarke-Pearson, and M. Davidson Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer New Engl. J. Med. 334 1996 1 6
24. M. Merlano, V. Vitale, R. Rosso, M. Benasso, R. Corvo, M. Cavallari, G. Sanguineti, A. Bacigalupo, F. Badellino, and G. Margarino Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy New Engl. J. Med. 327 1992 1115 1121
25. M. Muller Frequency representation in the rat cochlea Hear. Res. 51 1991 247 254
26. K. Noda, Y. Nishiwaki, M. Kawahara, S. Negoro, T. Sugiura, A. Yokoyama, M. Fukuoka, K. Mori, K. Watanabe, T. Tamura, S. Yamamoto, and N. Saijo Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer New Engl. J. Med. 346 2002 85 91
27. .OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart Free Radic. Res. 21 1994 355 370
28. G. Ramesh, and W.B. Reeves Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha Kidney. Int. 65 2004 490 499
29. R. Ravi, S.M. Somani, and L.P. Rybak Mechanism of cisplatin ototoxicity: antioxidant system Pharmacol. Toxicol. 76 1995 386 394
30. D. Reser, M. Rho, D. Dewan, L. Herbst, G. Li, H. Stupak, K. Zur, J. Romaine, D. Frenz, L. Goldbloom, R. Kopke, J. Arezzo, and T. Van De Water L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity Neurotoxicology 20 1999 731 748
31. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, M.A. Maiman, D.L. Clarke-Pearson, and S. Insalaco Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer New Engl. J. Med. 340 1999 1144 1153
32. L.P. Rybak, K. Husain, L. Evenson, C. Morris, C. Whitworth, and S.M. Somani Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system Pharmacol. Toxicol. 81 1997 173 179
33. T. Saito, Z.J. Zhang, Y. Manabe, T. Ohtsubo, and H. Saito The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs Eur. Arch. Otorhinolaryngol. 254 1997 281 286
34. S.D. Schaefer, J.D. Post, L.G. Close, and C.G. Wright Ototoxicity of low- and moderate-dose cisplatin Cancer 56 1985 1934 1939
35. S.H. Sha, and J. Schacht Salicylate attenuates gentamicin-induced ototoxicity Lab. Invest. 79 1999 807 813
36. C.H. Stengs, S.F. Klis, E.H. Huizing, and G.F. Smoorenburg Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs Hear. Res. 124 1998 99 107
37. K. Watanabe, S. Inai, K. Jinnouchi, S. Bada, A. Hess, O. Michel, and T. Yagi Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice Anticancer Res. 22 2002 4081 4085
38. N.I. Weijl, G.D. Hopman, A. Wipkink-Bakker, E.G. Lentjes, H.M. Berger, F.J. Cleton, and S. Osanto Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients Ann. Oncol. 9 1998 1331 1337